Two Sigma Advisers’s Loxo Oncology, Inc LOXO Stock Holding History

Two Sigma Advisers’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-87,800	Closed	-$12.3M	–	2514
2018 Q4	$12.3M	Sell	87,800 -4,300	-5%	-$653K	0.03%	507
2018 Q3	$15.7M	Buy	92,100 +33,700	+58%	+$5.66M	0.04%	453
2018 Q2	$10.1M	Buy	+58,400	New	+$8.78M	0.03%	588

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Two Sigma Advisers's LOXO Position: Q1 2019 in Review

Two Sigma Advisers sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 87,800 shares — an estimated $12.3M sold.

Two Sigma Advisers first reported a position in LOXO in Q2 2018 and held it in 3 quarters. The position peaked at $15.7M in Q3 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Two Sigma Advisers reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Two Sigma Advisers sold 87,800 Loxo Oncology, Inc shares in Q1 2019, an estimated $12.3M.
Two Sigma Advisers first reported a position in Loxo Oncology, Inc in Q2 2018 and held it in 3 quarters.
Two Sigma Advisers's Loxo Oncology, Inc position peaked at $15.7M in Q3 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Two Sigma Advisers's 13F filing for Q1 2019, filed 15 May 2019.